🔴NEWS ALERT: Belite Bio (🇺🇸Nasdaq: BLTE) has entered into a securities purchase agreement with an institutional investor. The gross proceeds of the offering is expected to be approximately $25 million. #BeliteBio #News Read More: https://lnkd.in/gFY8vZi3
Belite Bio’s Post
More Relevant Posts
-
The top Biotech & Pharma stories in one daily email - TLDR Biotech 🧬💊 | Founder, Head Editor | Sales Strategy and Consulting 🤝📈
TLDR Biotech weekend stock review! Some gnarly movers in the biotech space this past week - with one stock being up nearly 800%(!!!) intra-week. Check out the full thing below to see who that was, and for other winners and losers of the week in the biotech/pharma stock space. #tldrbiotech #pharmanews #biotechnews
Another Saturday, another TLDR Biotech stock review - covering the winners and losers of the preceding week. Link here: https://lnkd.in/gMfc7Q7N Or if you'd want to get this straight to your inbox, you can always subscribe 🙂 https://lnkd.in/gecXctqM #tldrbiotech #biotechnews #pharmanews
To view or add a comment, sign in
-
-
Check out this early system development snapshot – a pivotal "eureka" moment when we unexpectedly clogged the system with one of our initial THCa bricks. 😱⚙️ This challenge led to significant advancements in our extraction processes. Excited to discover more about our journey and industry innovations? Stay tuned and follow us for a deep dive into the world of cannabis extraction. Are you ready to join us on this enlightening path? #ExtractionEvolution #THCaBreakthrough #InnovationJourney #extractionindustry #thcadiamonds #liveresin
To view or add a comment, sign in
-
-
SPAC Feed: Oppenheimer Initiates Coverage of Zura Bio Ltd – - ZURA - with … – msnNOW - https://lnkd.in/eBPDpEtD Oppenheimer Initiates Coverage of Zura Bio Ltd – - ZURA - with … msnNOW Source: Oppenheimer Initiates Coverage of Zura Bio Ltd –… #SPACs #SPACNews #SPAC #IPO #markets #news #capitalmarkets #trends #goingpublic
To view or add a comment, sign in
-
The Nasdaq Biotech Index has been 'the same price' for the past 20 months. Specifically, it has traded within 6% either side of today's closing price over that time. While it has spent some time 'digesting', its price action is now becoming quite constructive. Also, it's hardly a crowded theme. September 16, 2023 by Rob Zdravevski rob@karriasset.com.au #biotechnology #biotechs
To view or add a comment, sign in
-
-
Are you attending BIO Investor Forum 2023, this month? Book a meeting with our Director, Paul Cronin, by Searching 'Scendea' in the partnering platform or get in touch info@scendea.com - #Partnering #DrugDevelopment #RegulatoryAffairs #BiotechEvents
To view or add a comment, sign in
-
-
Cannabis plant is an excellent bioremediators, soaking up a large majority of whatever the roots come in contact with. Even at extremely low levels, heavy metals such as lead, arsenic, mercury, and cadmium can be hazardous to one’s health. Protect your business and your consumers by testing for heavy metals at Certainty Analytical! #cannabis #cannabistesting #biotech #rochesterny #cannabisindustry #labtesting #newyork #cannabisresearch #cannabisnews #NYCannabis #CannabisBusiness
To view or add a comment, sign in
-
-
Come and be a part of our Annual 2023 Shareholders Meeting in Florida on December 27th. We welcome both members and guests. To secure your spot, please email us at info@evergrowthinvest.com, and don't hesitate to reach out if you have any questions. #investing #stocks #biotech #biotechnology #hedgefund #hedgefunds #lifescience #evergrowthbiohealthcarecapital
To view or add a comment, sign in
-
-
Did you know there are thousands of different cannabis strains? Medcan Australia follows three metrics when it comes to selecting different strains, ensuring we produce the highest quality cannabis possible. These include the active cannabinoid content (THC/CBD) of the specific strain, the biomass per square metre, and flowering time. For a more in-depth rundown, watch episode 3 of ‘Inside Medcan: Australia’s Largest Indoor Cannabis Farm’ on our page.
To view or add a comment, sign in
-
-
IOFINA PLC (AIM:IOF, OTC:IOFNF) has unveiled plans for a partnership with a new brine supply associate and will construct its latest IOsorb iodine plant, IO#10, in Western Oklahoma. Choosing the area stems from its ability to supply feedstock for the iodine operation, Collaboration between Iofina and its unnamed partner is underway, focusing on design strategies to optimise brine delivery to the IO#10 site. Company resources, including existing cash and loan facilities, will finance the new site. Initial operations for IO#10 are projected to commence in the fourth quarter of 2023, with brine water processing anticipated around mid-2024. While specifics regarding the construction timeline remain undisclosed, expectations for IO#10's design and production capabilities closely resemble those of IO#9. More at #Proactive #ProactiveInvestors #AIM #OTC #IOF #IOFNF #IOFINA #IODINE http://ow.ly/VJnA104Yobw
Iofina making plans for its tenth iodine plant
proactiveinvestors.co.uk
To view or add a comment, sign in
Congratulations!